Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Argentina

Political Trajectory Key For Biotechnology Ambitions

November 2011 | Industry Trend Analysis

BMI View: While we do not foresee an improvement in Cuba's overall business environment any time soon, we maintain that the country's biopharmaceutical sector remains largely under appreciated. However, aided by its regional and international supporters, it seems a series of innovative trade partnerships could help the country market its low-cost medicines.

To read the full article, please choose one of the following options:

Subcribers please log in